Page - 1 Medical Devices & Diagnostics Global Strategies Strategies and Operational Management for: Product Development – Concept through Commercialization.

Slides:



Advertisements
Similar presentations
Elizabeth Mansfield, PhD OIVD Public meeting July 19, 2010
Advertisements

Project Quality Plans Gillian Sandilands Director of Quality
1 Testing in the Open Market Testing in the Open Market AAAS Colloquium on Personalized Medicine: Planning for the Future June 2, 2009 Courtney C. Harper,
An Essential Component of Health Systems Strengthening Presented on: May 23, 2011 Akiko Maeda Health, Nutrition & Population Network The World Bank.
Roadmap for Sourcing Decision Review Board (DRB)
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
Business Development Licensing Strategic Marketing HFA-Consulting.com Pharmaceutical Business Development & Licensing Consultancy HFA provides specialist.
1/16 Service Package for Life Science Start-Ups Regulatory, Reimbursement, Quality and Clinical Research In Europe and the USA UK Office: 27 Old Gloucester.
PROJECT TITLE Project Leader: Team: Executive Project Sponsor (As Required): Date: Month/Day/Year 110/17/2014 V1.
The Statisticians Role in Pharmaceutical Development
1st Global QA Conference & 21st SQA Annual Meeting Falcon Consulting Group, LLC 1 Phase I Clinical Study Audits “A Deeper Scrutiny” Cheryl J. Priest, R.N.
EDC PHARMA SERVICES Capacity. Expertise. Solutions. Technology.
Health Line of Business Revised Health Domains January 26, 2005 Outcomes / Domains have been revised.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES NATIONAL INSTITUTES OF HEALTH Working with FDA: Biological Products and Clinical Development Critical Path.
SUCCESS FACTORS IN THE PHARMACEUTICAL MARKETPLACE
Career Opportunities for PharmDs in the Pharmaceutical Industry: Research & Development.
© 2012 AT&T Intellectual Property. All rights reserved. AT&T, the AT&T logo and all other AT&T marks contained herein are trademarks of AT&T Intellectual.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Strategic Approaches to Outsourcing to Clinical Research Organizations Kate Giovino Director of Clinical Operations.
Protocol Complexity as a Factor in Vendor Management Compliance Risk
MethodGXP The Solution for the Confusion.
Achieving and Demonstrating “Quality-by-Design” with Respect to Drug Release/dissolution Performance for Conventional or Immediate Release Solid Oral Dosage.
Good Clinical Practice (GCP)- An introduction Dr Noor Ibrahim Mohamed Sakian.
Figure 4.1 NEW PRODUCT DEVELOPMENT PROCESS Finance Corporate strategy and portfolio decisions Regulatory affairs Marketing and sales + market research.
Continual Service Improvement Process
Challenges to Indian Multinational Cos. P. M. Kelkar 18 th March, 2006 Thorale Bajirao Peshwe Sabhagruha, Thane.
Yesterday, today, and tomorrow
Target Institute of Medical Education & Research (TIMER) Provides Clinical Research services to Pharmaceutical, Biotechnology product companies right.
1 Value Assessment of Development-Stage Assets Pharmaceutical Products, Medical Devices, and Related Intellectual Property Frank S. Castellana, M.D., Eng.Sc.D.
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Contents Integrating clinical trial data Working with CROs
Global Product Development
Stefan Franzén Introduction to clinical trials.
PRODUCT TRANSFER.
Product Development Chapter 6. Definitions needed: Verification: The process of evaluating compliance to regulations, standards, or specifications.
Cavendish Scott, Inc. 1 Regulatory and Statutory Compliance: It’s Everybody’s Business! Diana Lough Cavendish Scott, Inc.
SIPLAS RO is a full service contract research organization CRO, offering nanotechnology, biopharmaceutical and medical device companies comprehensive.
Product Documentation Chapter 5. Required Medical Device Documentation  Business proposal  Product specification  Design specification  Software.
Presented by: Ken Imler Sr. Vice President RAQA Arrow International Working with Suppliers: Forming Strategic Alliances to Accelerate Compliance & Improve.
普 华 永 道 Phase 1: Project Preparation Phase 1: Project Preparation Phase Overview Phase Overview.
Paul Hardiman and Rob Brown SMMT IF Planning and organising an audit.
Molecule-to-Market-Place Quality
Development and Approval of Drugs and Devices EPI260 Lecture 6: Late Phase Clinical Trials April 28, 2011 Richard Chin, M.D.
Agenda for Session Compliance in Clinical Research
Regulatory Decision Making D. Kathleen Wright, Reviewer Division of Microbiology Office of In Vitro Diagnostic Device Evaluation & Safety ( OIVD ) Food.
UPCOMING CHANGES TO IN-VITRO DIAGNOSTICS (IVDs) AND LABORATORY DEVELOPED TESTS (LDTs) REGULATIONS Moj Eram, PhD November 5, 2015.
The Second Annual Medical Device Regulatory, Reimbursement and Compliance Congress Presented by J. Glenn George Thursday, March 29, 2007 Day II – Track.
UNIT-II CLINICAL DATA. UNIT-II CLINICAL DATA: Clinical Data, Application, Challenges, Solutions, Clinical Data Management System.
Second Meeting of the FDA/ACPS Process Analytical Technology: Closing Remarks Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Sciences.
Center for Biologics Evaluation and Research, FDA Site Visit Introduction Kathryn M. Carbone, M.D. Associate Director for Research.
FINDING A PRACTICUM Lauri Rich – Career Services Ryan Gallagan- Career Services
Win Phillips, Ph.D Win Phillips, Ph.D. Clinical Assistant Professor University of Missouri Columbia, MO.
Proposal and Company Information Document CONTENT About Indagatio Research Our Research Offerings Why Indagatio Research Our Work Process Project Snapshot.
Responsibilities of Sponsor, Investigator and Monitor
RAC Regulatory Affairs Certification
“Your sustainable compliance and remediation partners”
Responsibilities of Sponsor, Investigator and Monitor
Irena Prat and Josée Hansen World Health Organization
LNH Pharma A Trusted Partner.
Khalid “Kal” Mentak, PhD
Reasonable Assurance of Safety and Effectiveness: An FDA Division of Cardiovascular Devices Perspective Bram Zuckerman, MD, FACC Director, FDA Division.
Quality System.
2016 Procurement Framework Contract Management
BY – Stravis Consultants “Bright Solutions. Valuable Outcomes.”
Transorganizational Change
By Jeff Burklo, Director
Medical Device Design and Development
MAZARS’ CONSULTING PRACTICE Helping your Business Venture Further
MAZARS’ CONSULTING PRACTICE Helping your Business Venture Further
‘Delivering better value from professional services’
Presentation transcript:

Page - 1 Medical Devices & Diagnostics Global Strategies Strategies and Operational Management for: Product Development – Concept through Commercialization Global Regulatory Strategies and Submission Clinical Trial Design and Clinical Development Medical Device and Diagnostics Budget Models Medical Device and Diagnostics Biostatistics Models Quality Management including Audits Consulting and Contracting to Other CRO’s and Sponsors Strategic Guidance When It Counts “Get it right the first time”™

Page - 2 Medical Devices & Diagnostics Global Strategies Specialty sectors:  Wound Care and Ophthalmology Device and Pharma  Neurology and Oncology Diagnostics and Devices  Women’s Health Diagnostics and Devices  Infectious Disease Diagnostics  Biomarkers Sample Collection and Nanotechnology  Drug Delivery Device Studies – Combination Products, Human Factors Engineering, Instructions for Use  Feasibility and Site Qualification Expertise - SiteID™  Pre-FDA Inspection Audits,and QMS Audits  Clinical Trial Supply Chain Audits Strategic Guidance When It Counts “Get it right the first time”™ S

Page - 3 “Get it right the first time” TM Value Added Expertise –We make you money Aligning Business, Regulatory and Clinical Trial Objectives Our mission is to support your company to build the Value Proposition We provide direct access to C-level experts for the Sponsor We provide a senior team from Product Development through Regulatory Review, Clinical Trial, Submission and Post-Market We imbed with your team early to assess how the technical mission is designed to support the ultimate Value Proposition goals We also provide Strategic Guidance on a selected basis We build the specific Value Proposition sequence of stakeholder needs We provide the infrastructure to carry out the regulatory and clinical trial mission interfacing with the appropriate Sponsor team members We build the cost-effective Roadmap “up the Pyramid” We are on your side - the strategic and operational glue for you to: “Get it right the first time”

Page - 4 Claim Device Functionality Literature Background and Technical File Longitudinal, non- interventional to establish Sensitivity & Specificity Case Control and/or Cohort studies (healthy/afflicted), depending best applicability of either Usability, Reliability and Device Accuracy Design, Manufacturing & Engineering Data Literature, Background and Technical File Clinical utility Standard of Care Typical deliverable*: Value Dossier Increasingly strong claims Typical deliverable: ROC curve Typical deliverable: Descriptive statistics and correlation of device readings to confirmed conditions Typical deliverable: inter-device and inter-operator coefficient of variation Typical deliverables: Bench test & regulatory standards data Typical deliverables: Clinical Evaluation Report, per MedDev Rev 3 Increasing Value Decreasing Risk Value Proposition 2 Prong Comparison and intervention vs. Gold Standard Evidence Convert Development into Organized Success Lean & Flexible Program Management - When it Counts BUILDING THE RISK BASED VALUE PROPOSITION

Page - 5 Dr. Alan J. Touch Over 35 years senior-level multi-national and entrepreneurial operating management and consulting experience including global CRO executive leadership Device, Diagnostics, Wound Care and Ophthalmology Product Development Strategist ‒Founder, CEO and Principal Strategist of Avodex Partners ‒Prior Principal Strategist, INC Research Biographical Details Device and IVD and pharmaceutical development, regulatory strategies and clinical trials Discovery, design, development, design control and validation, clinical trial, regulatory submissions Ophthalmology drug development including formulation and bioavailability Ophthalmology medical device and IVD clinical trial protocol development and oversight Medical device and diagnostics developer at the operational and C-Level Device and drug manufacturing scale-Up, QMS and production oversight Understanding of cGMPs, GCPs, essential principles and MDD compliance Post-approval CLIA, US and EU reimbursement strategies and management Drug Delivery Device Related Issues – Human Factor, Dosing, Design, Instructions for Use Clinical trial management and oversight Expertise

Page - 6 Regulatory Strategies and Business Outcome Objectives Design Control Development QSR and ISO Validation and Verification Testing Clinical Trial Mgmt Risk Assessment Regulatory Submissions and Approvals Post – Market Requirements or Actions Avodex Partners - Product Life cycle services © 2013 Avodex Partners, LLC 6 A seamless continuous process From concept through commercialization and post-market Experience & Expertise Product Life Cycle Indications Trials Regulatory Strategies/Submissions Human Factors and Usability Studies Capabilities Device and Diagnostics Biostatistics Models Clinical Trial Operational Oversight Cost Sensitive Medical Device Budget Models Expert Submission Medical Writing Expert Marketing Medical Writing

Page - 7 The Regulatory Continuum - Devices © 2013 Avodex Partners 7 INC Research Clinical Development Concept Design development Pre-IDE modelClinical Trial Regulatory Submission Regulatory Services Study Design with Historical Controls New Presentation New Indication Marketing Application Including Safety and Performance Dossier Post-Market Life Cycle Surveillance Medical Device Adverse Event Reporting Avodex Medical Device and Diagnostics Regulatory and Clinical Development Biostatistics protocol development SAP/ Study Biometrics Quality Assurance cGMP/QMS Design Control Hand-Off Regulatory Strategy and Intelligence Clinical Trial Design Usability Study Design pre-IDE prep Clinical Trial Applications or notifications to EC/IRB and Study Start Up 510(k)/PMA CE Mark Other Safety and Performance Dossier 510(k)/PMA CE Mark Other Safety and Performance Dossier

Page - 8 Medical Device Strategic Services Regulatory Consulting Services Design and Validation Consulting and Management Quality Management Systems Consulting Protocol Development and Review Clinical Development including project specific budgets Clinical Trials Management and Oversight Device and Diagnostics Internal Global Consulting Due Diligence and M&A Support – Consulting Post Approval Voluntary and Mandated Surveillance

Page - 9 Strategic and Operational Services for Diagnostics Safety and Performance Study Strategies ROC Curve / Verification Study Design and Budget Models Validation of Interventional Claims – Specialized Models Biomarker/ IVD Performance Sample Collection Models Biomarker/IVD Clinical Trial Models tied to Performance Global Compliance Regulatory Strategies and Tactics Device Centric Biostatistics/Data Management Models Risk Based Medical Monitoring Decisions and Rationale MDR Reporting requirements assessment and strategies

Page - 10 Clinical Development Services Study/Protocol Design and Review Sample size Calculations and Biometrics Site Selection Feasibility Questionnaires Assure that Prototype Sensitivity, Specificity and Reproducibility results can be carried over to the Manufacturing Floor Optimize Clinical Trial Design for Indication Establish Statistically Based Pre-Clinical and Clinical Trial Study Procedures Ensure world-wide device regulatory and clinical trial integrated processes

Page - 11 M&A, Product Development & IP Advisory Services: Due Diligence, Capital Formation, Acquisition or Exit Mergers & Acquisitions/Sales Strategic Acquisition Plan Formulation Business Plan Drivers Target List Development Target Valuation Analysis Risk Based Valuation Proposition Modeling Market Segment Analysis Major Customer Buyer Behavior Competitive Landscape SWOT Analysis Merger & Acquisition Due Diligence Financial Operations Engineering/Research Purchasing Marketing and Distribution Regulatory Status Analysis Go to Market Status Analysis Reimbursement Analytics and Strategies Product Development Planning Market Requirements Document Program Development Analysis and Budgets Cost Driver Analysis Bench Top to Commercialization Management Regulatory and Clinical Trials Management Protocol Development Clinical Trial Design Project Management Regulatory Strategies and Filings Technology Transfer/Acquisitions License Agreements Advisory Business Plan Assessment and Writing

Page - 12 Value Proposition Build ~ Speed to Market Specialists Strategic Interventional Management Time to Value Proposition Always a Factor Product Life Cycle Experience & Expertise Indications Trials Experience & Expertise Regulatory Strategies/Submissions Expertise Device and Diagnostics Biostatistics Models Clinical Trial Operational Oversight Capabilities Human Factors and Usability Studies Expertise Cost Sensitive Medical Device/Diagnostics Budget Models Submission and Marketing Medical Writing Ensure your critical front end decisions are made with knowledge BUILD THE RISK BASED VALUE PROPOSITION NOW Make Avodex Partners your “Speed to Market” Team Today